Empagliflozin is safe and tolerable in patients with compensated or decompensated cirrhosis

被引：0
|
作者：
Shen, I. [1 ]
Danta, M. [1 ,2 ]
机构：
[1] UNSW, Sydney, Australia
[2] St Vincents Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
190
引用
收藏
页码：66 / 67
页数：2
相关论文
共 50 条
  • [1] Outcomes for Patients on DOACs in Compensated and Decompensated Cirrhosis
    Aslam, Aysha
    Gombar, Saurabh
    Kwo, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S893 - S894
  • [2] Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
    Zipprich, Alexander
    Garcia-Tsao, Guadalupe
    Rogowski, Sebastian
    Fleig, Wolfgang E.
    Seufferlein, Thomas
    Dollinger, Matthias M.
    LIVER INTERNATIONAL, 2012, 32 (09) : 1407 - 1414
  • [3] Mucosal and Fecal Microbiota in Patients With Compensated and Decompensated Liver Cirrhosis
    Tedjo, Danyta
    Pijls, Kirsten
    Koek, Ger
    Budding, Andries E.
    Savelkoul, Paul
    Masclee, Ad
    Penders, John
    Jonkers, Daisy
    GASTROENTEROLOGY, 2016, 150 (04) : S219 - S220
  • [4] Abnormal hemorheological properties in patients with compensated and decompensated hepatic cirrhosis
    Anwar, MA
    Rampling, MW
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2003, 29 (02) : 95 - 101
  • [5] Determinants of platelet count are different in patients with compensated and decompensated cirrhosis
    Latorre, Raquel
    Vaquero, Javier
    Rincon, Diego
    Puerto, Marta
    Ponce, Maria D.
    Sarnago, Fernando
    Matamoros, Jose A.
    Ramon, Enrique
    Elizaga, Jaime
    Banares, Rafael
    Ripoll, Cristina
    LIVER INTERNATIONAL, 2016, 36 (02) : 232 - 239
  • [6] Prognostic factors in compensated and decompensated cirrhosis
    Ripoll C.
    Zipprich A.
    Garcia-Tsao G.
    Current Hepatology Reports, 2014, 13 (3) : 171 - 179
  • [7] A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease
    Shen, Ivan
    Stojanova, Jana
    Yeo, Malcolm
    Olsen, Nick
    Lockart, Ian
    Wang, Max
    Roggeveld, Jan
    Heerspink, Hiddo J. L.
    Greenfield, Jerry R.
    Day, Richard
    Danta, Mark
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (10) : 2529 - 2538
  • [8] Smoking and obesity promote systemic inflammation in patients with compensated and decompensated cirrhosis
    Hofer, Benedikt
    Simbrunner, Benedikt
    Semmler, Georg
    Schwarz, Michael
    Balcar, Lorenz
    Hartl, Lukas
    Jachs, Mathias
    Pomej, Katharina
    Paternostro, Rafael
    Muellner-Bucsics, Theresa
    Schwabl, Philipp
    Scheiner, Bernhard
    Trauner, Michael
    Mandorfer, Mattias
    Reiberger, Thomas
    JOURNAL OF HEPATOLOGY, 2023, 78 : S244 - S244
  • [9] Etiologies for In-Hospital Mortality in Patients With Compensated and Decompensated Hepatic Cirrhosis
    Pemmasani, Gayatri
    Mandal, Amrendra
    Koya, Hayas Haseer
    John, Savio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S949 - S950
  • [10] ERYTHROPOIETIN RESPONSE TO ANEMIA IN COMPENSATED AND DECOMPENSATED CIRRHOSIS
    SICILIANO, M
    TOMASELLO, D
    MILANI, A
    ROSSI, L
    HEPATOLOGY, 1994, 20 (04) : A399 - A399
12345